lncRNA POU6F2-AS1 Regulated by KIAA1429 Contributes to Colorectal Cancer Progression in an m6A Modification Manner-Reference-Cited by-同舟云学术

lncRNA POU6F2-AS1 Regulated by KIAA1429 Contributes to Colorectal Cancer Progression in an m6A Modification Manner

Published:2023-12-16 Issue: Volume: Page:
ISSN:1073-6085
Container-title:Molecular Biotechnology
language:en
Short-container-title:Mol Biotechnol

Author:

Lu Dunfeng,Chen Aihua^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s12033-023-00986-7.pdf

Reference28 articles.

1. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33.

2. Biller, L. H., & Schrag, D. (2021). Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA, 325(7), 669–685.

3. Ciardiello, F., Ciardiello, D., Martini, G., Napolitano, S., Tabernero, J., & Cervantes, A. (2022). Clinical management of metastatic colorectal cancer in the era of precision medicine. CA: A Cancer Journal for Clinicians, 72(4), 372–401.

4. Chi, Y., Wang, D., Wang, J., Yu, W., & Yang, J. (2019). Long non-coding RNA in the pathogenesis of cancers. Cells, 8(9), 1015.

5. Yan, H., & Bu, P. (2021). Non-coding RNA in cancer. Essays in Biochemistry, 65(4), 625–639.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silencing of KIAA1429, a N6‐methyladenine methyltransferase, inhibits the progression of colon adenocarcinoma via blocking the hypoxia‐inducible factor 1 signalling pathway;Journal of Biochemical and Molecular Toxicology;2024-08-31

2. Role and mechanism of KIAA1429 in regulating cellular ferroptosis and radioresistance in colorectal cancer;Biomolecules and Biomedicine;2024-06-05

3. The m6A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN;Molecular Cancer;2024-03-16